| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |